What's Next In Biotech's Deal Playbook?

By Rachael Bushey and Jennifer Porter

To break new ground in biotech requires researchers to be relentlessly innovative in the lab. And when it comes to finding solid investment in today’s hard-hit biotech market, company leaders must be just as creative in the boardroom. How can companies and boards stabilize and grow the bottom line after a particularly tough year?